[Stosstherapy with steroid-containing combination preparation "Ambene" in the acute stages of rheumatic diseases].
446 patients with acute rheumatic diseases were treated intensively for an extremely short peroid with Ambene ampoules and Ambene coated tablets. Physical measures were used from the first day of treatment. Bed rest was dispensed with. Under this plan of treatment, 55.3% of the patients were free of complaints within 3 days and 33.4% within 6 days. In spite of extremely high doses of phenylbutazone, no noteworthy side effects appeared.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000535:Aluminum / Q000627:therapeutic use; D000632:Aminopyrine / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010347:Patient Care Planning; D010653:Phenylbutazone / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014805:Vitamin B 12 / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D000632:Aminopyrine; D008012:Lidocaine; D000535:Aluminum; D010653:Phenylbutazone; D014805:Vitamin B 12; D005998:Glycine
Behandlung akuter Stadiev rheumatischer Erkrankungen